Related Experiment Videos
[Community-acquired pneumonia: considerations on ambulatory management]
1Département de médecine interne, Centre hospitalier universitaire vaudois, Lausanne.
Schweizerische Medizinische Wochenschrift
|March 29, 1997
Summary
Community-acquired pneumonia is common in outpatients, especially the very young and elderly. Empirical antibiotic therapy, often with macrolides, is effective, with targeted treatment improving public health outcomes.
Area of Science:
- Infectious Diseases
- Pulmonology
- Epidemiology
Context:
- Community-acquired pneumonia (CAP) is a prevalent outpatient illness, particularly affecting the very young and elderly.
- Existing clinical data often derive from hospitalized patients, potentially misrepresenting CAP epidemiology and severity in the general population.
- The significance of certain pathogens, like Mycoplasma pneumoniae, and overall prognosis may be underestimated in outpatient settings.
Purpose:
- To highlight the epidemiological characteristics of CAP in outpatients.
- To discuss the limitations of existing literature based on hospitalized patients.
- To evaluate current empirical treatment strategies and propose a more logical public health approach.
Summary:
- CAP is frequent in outpatients, with highest incidence in the very young and elderly, rarely requiring hospitalization.
- Underestimation of certain pathogens (e.g., Mycoplasma pneumoniae) and overestimation of prognosis severity are noted due to data skewed by hospitalized patients.
- Empirical antibiotic therapy is standard; macrolides are effective in Switzerland, but tailoring treatment to probable pathogens based on patient demographics and comorbidities offers a more rational public health strategy.
Impact:
- Informs clinical practice regarding the management of outpatient CAP.
- Suggests a shift towards more personalized empirical antibiotic selection for improved public health.
- Underscores the need for research focused on the outpatient CAP population to refine treatment guidelines.